Few CA Pharmacies Offer RPh-Prescribed Contraception, Despite Law

By December 13, 2017

The law, enacted in 2013 and implemented in 2016, allows pharmacists to prescribe birth control to increase access to oral contraceptives, patches, rings, and injections for women.

Hormonal Contraceptives and Breast Cancer: What's the Link?

December 07, 2017

Findings from nationwide study in Denmark show small absolute increase in breast cancer risk

IUD Use and Cervical Cancer Risk: What's the Link?

By November 09, 2017

The data showed women who used IUD had a lower occurrence of cervical cancer (odds ratio [OR] 0.64, 95% CI: 0.53-0.77).

ACOG: Recommendations for LARC Initiation and Management

October 26, 2017

Insertion of IUD should be offered after first-trimester uterine aspiration, on same day as abortion

Lidocaine Found to Reduce Pain During IUD Insertion

September 11, 2017

Researchers randomized 95 adolescents and young women (ages 14 to 22) receiving a 13.5-mg levonorgestrel IUD to either a 10-mL 1% lidocaine paracervical block or a sham block.

Does Timing of Postpartum IUD Insertion Impact Breastfeeding Outcomes?

By September 07, 2017

Patients were randomized (1:1) to receive immediate device insertion postpartum (n=132) or delayed device insertion (n=127), which occurred 4-12 weeks postpartum

Oral Contraceptives May Reduce Rheumatoid Arthritis Risk

August 21, 2017

The researchers found that ever and past OC users had a reduced risk of anticitrullinated protein antibodies (ACPA)-positive RA compared with never users.

Targeting Premenstrual Breakthrough of Depression with OCs: Is it Effective?

By August 18, 2017

Premenstrual exacerbation (PME) of depression has been found to occur in roughly two-thirds of women with depressive disorders.

Contraindication Added to OCs, Other Ethinyl Estradiol-Containing Drugs

By August 10, 2017

The concomitant use of HCV drug combinations containing ombitasvir, paritaprevir/ritonavir, with or without dasabuvir is contraindicated due to the potential for liver enzyme elevations.

Dimethyl Fumarate and Oral Contraceptives: Drug Interactions Explored

By August 08, 2017

Delayed-release DMF exerts anti-inflammatory and neuroprotective properties for the treatment of relapsing multiple sclerosis, a disease that often develops in women between the ages of 20 and 40.

Liletta Approved to Prevent Pregnancy for up to Four Years

By August 07, 2017

The FDA's approval of the supplemental New Drug Application (sNDA) was based on efficacy and safety data from the ongoing Phase 3 ACCESS IUS trial.

ACOG: Recommendations for Counseling Teens About Contraception

July 27, 2017

Ob-gyns should address contraceptive needs, expectations, and concerns, regardless of patient age

Obtaining OTC Emergency Contraception May Still Be Tough for Teens

July 05, 2017

'Mystery shopper' study found pharmacists still refusing sales

CDC: Teen Birth Rates Reach Record Low

July 05, 2017

CDC researchers used birth records for nearly 100% of the births in the United States in 2016. The teen birth rate was 20.3 births per 1,000 female teens in 2016, compared to 41.5 births per 1,000 in 2007, according to the report.

NDA Resubmitted for Twirla Contraceptive Patch

By June 28, 2017

In the NDA resubmission, the Company included safety and efficacy data from the Phase 3 trial SECURE, the manufacturing information, and a summary response to the CRL.

HIV Prevention Among HIV-Discordant Couples Trying to Conceive

By June 01, 2017

A review of recent data showed that insemination with sperm from an HIV-negative donor is the safest option for a discordant couple where the woman does not have HIV but the man is HIV-positive.

Birth Control Pills Recalled Due to Out of Sequence Tablets

By May 30, 2017

Mibelas 24 Fe is an oral contraceptive indicated to prevent pregnancy in women who choose to use oral contraceptives.

Contraceptive ID'd as Culprit in Patient with Shortness of Breath, Chest Pain

By May 30, 2017

While IUD displacement has been discussed in the literature, the authors could not find a similar case which showed a displaced IUD reaching the diaphragm and causing chest pain.

Generic Minastrin 24 Fe Available

By March 16, 2017

The product is available in blister cards containing 28 tablets (24 active tablets containing 1mg of NA and 20mcg of EE and 4 non-hormonal placebo pills containing 75mg of Fe).

New Review Makes the Case for OTC Oral Contraceptives

By March 14, 2017

Researchers stated that there is a need for improved contraceptive access for teens, as proven by the increase in use of hormonal emergency contraceptives after the FDA approved the OTC availability under Plan B in 2012.

How Long Does Zika Virus Stay in the Body?

February 16, 2017

Even though Zika virus was found to linger for 3 months in semen, scientists say recommendations urging abstinence, condoms for 6 months after infection should still be followed.

Contraceptive, AED Choice May Impact Unintended Pregnancy Rate in Epilepsy

By February 08, 2017

In a study of female patients with epilepsy, retrospective data found that unintended pregnancy was common and varied by contraceptive type and antiepileptic drug (AED) stratification. Full findings are published in Neurology.

Gel-Based Alternative to Traditional Vasectomy in the Works

February 08, 2017

Primate study shows injected gel may one day be alternative to traditional vasectomy

Preterm Risk Up For Subsequent Births After Pregnancy Termination

January 17, 2017

A short interpregnancy interval after termination of pregnancy is associated with increased risk of preterm birth in subsequent birth, according to a study published in the February issue of Obstetrics & Gynecology.

FDA to Review Liletta Use for Up to 4 Years

By January 04, 2017

Allergan and Medicines360 announced that the Food and Drug Administration (FDA) has accepted for filing the supplemental New Drug Application (sNDA) for Liletta (levonorgestrel-releasing intrauterine system).

Top 10 Most Costly Conditions in the U.S. Announced in New Report

By December 27, 2016

The highest amounts of spending were seen with these 10 conditions.

Labeling Updated for IUDs Regarding Perforation Risk

By December 27, 2016

Data from a large, 1-year postmarketing safety study conducted in Europe found that lactation at the time of insertion of an IUD/IUS was associated with an increased risk of perforation.

Hormonal Contraceptive Safety Investigated in Women with Diabetes

By December 15, 2016

In a study published in Diabetes Care, researchers reported that the absolute risk of thromboembolism among women with type 1 or type 2 diabetes using hormonal contraceptives was low.

Diabetes, Hormonal Contraception and the Risk of Thromboembolism

December 06, 2016

For women with diabetes who are using hormonal contraception, the absolute risk of thromboembolism is low, with the lowest rates seen with use of intrauterine and subdermal contraceptives, according to a study published online in Diabetes Care.

CDC Announces 7 U.S. Public Health Priorities

By December 05, 2016

The Centers for Disease Control and Prevention (CDC) issued the final report on the Winnable Battles program which highlights public health priorities with large-scale impact on health and strategies that may help to address them.